Comment

FDA Safety Communication: FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis

CAPTCHA
This is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Scroll to Top